Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Missouri · 2025 Regular Session · Bill

SB 175: Enacts provisions relating to insurance coverage for prescription insulin drugs

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 175 is a bill introduced in the Missouri Senate on December 1, 2024. According to its official title, it concerns: Enacts provisions relating to insurance coverage for prescription insulin drugs. Primary sponsor: Maggie Nurrenbern (Democratic). Most recent recorded action (January 23, 2025): Second Read and Referred S Insurance and Banking Committee.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Enacts provisions relating to insurance coverage for prescription insulin drugs

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Maggie NurrenbernPrimary sponsorDemocraticSenate17

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Second Read and Referred S Insurance and Banking Committee
  2. S First Read
  3. Prefiled

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source